This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Daniel Levine
Daniel B. Levine
Special Counsel
Shanghai +86 21 6036 2507 dlevine@cov.com Download V-card

Daniel B. Levine is special counsel in the firm’s Shanghai office.  He advises Chinese and non-Chinese companies in complex outbound and inbound direct investment transactions.  Formerly resident in the firm’s New York office, Mr. Levine has extensive experience with both China-based and non-China-based public and private mergers and acquisitions, joint ventures, leveraged buy-outs, going-private transactions, and other transactional matters.  He frequently speaks and writes on trends in Chinese outbound direct investment and strategies for approaching destination country legal and regulatory challenges, including national security reviews in the United States by the Committee on Foreign Investment in the United States (CFIUS).

  • Telular Corporation in its sale to Avista Capital Partners for $253 million.
  • Illumina, Inc. in its acquisition of Verinata Health, Inc. for up to $450 million in upfront and contingent payments.
  • MidFirst Bank in its acquisition of Presidential Financial Corporation from Harbert Private Equity and the Belfer family.
  • One Equity Partners in its minority investment in Grupo Phoenix, a leading packaging company in the Americas.
  • A leading private equity fund in the formation of the largest veterinary products company in the United States and the subsequent sale of the fund’s interest therein.
  • A leading middle-market private equity fund in the initial and add-on acquisitions forming the largest integrated retail property services firm in North America.
  • A US-listed technology company in the partial spin-off of its Greater China operations.
  • An insurance and administrative services company in the $1.25 billion sale of its Medicare Part D Business and the spin-off of its remaining businesses to its public shareholders.
  • The special committees of a Hong Kong satellite company and a PRC mobile retailer in going-private transactions.
  • A middle-market private equity fund and its portfolio companies in acquisitions, sales, debt restructurings, dividend-recapitalization and pre-IPO restructuring transactions.
  • Financial advisors in US-based mergers and acquisitions.

Previous Experience

  • Bear, Stearns & Co., Inc., various positions, including vice president and collateralized debt obligations structurer in the Financial Analytics and Structured Transactions Group, and mergers and acquisitions associate in the Corporate Finance Department (1997-2001).
  • New York Super Lawyers, Mergers & Acquisitions "Rising Star" (2013)